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Nitric oxide synthase activity in human breast cancer
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S_mmmmary Nitric oxide (NO) is generated by a family of isoenzymes (NO synthases) expressed in a wide range
of mammalian cells. We have recently reported NO synthase expression in human gynaecological cancers. In
this study we have assessed the activity and distribution of NO synthase in a series of human breast tumours
and in normal breast tissue. Calcium-dependent (constitutive) and -independent (inducible) NO synthase
activity, as well as NO biosynthesis, was high in invasive tumours compared with benign or normal tissue.
Furthermore, for invasive ductal carcinomas, NO biosynthesis was significantly greater for grade III compared
with grade II tumours. Immunohistochemical investigations revealed immunolabelling with a monoclonal
antibody to murine inducible NO synthase predominantly within tumour-associated macrophages.
Immunolabelling with a polyclonal antiserum raised against rat brain NO synthase was also observed in
vascular endothelial and myoepithelial cells. Thus NO synthase is expressed in human breast tumours, where
its presence correlates with tumour grade.
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Since the discovery in 1987 that vascular endothelial cells are
able to synthesise NO from L-argmnie (Palmer et al., 1987),
the existence of this biochemical pathway in many other cell
types has been thoroughly documented and its relevance in
biology is becoming apparent (Moncada et al., 1991). This
inorganic free radical gas, synthesised by a family of isoen-
zymes called NO synthases (Knowles and Moncada, 1994),
plays a vital role as a cell signalling molecule in the vascular,
nervous and immune systems (Moncada et al., 1991). It is
also a cytostatic/cytotoxic mediator when generated at higher
concentrations by activated macrophages and endothelial
cells (Marletta et al., 1988; Li et al., 1991). The role ofNO in
tumour biology, however, is poorly understood.
Several tumour cell lines express NO synthases (Forstmann
et al., 1990; Sherman et al., 1993; Werner-Felmayer et al.,
1993; Jenkins et al., 1994), and we have recently reported NO
synthase activity in human ovarian and uterine tumour tissue
(Thomsen et al., 1994). The correlation observed between
enzyme activity and tumour grade suggests that NO plays a
role in the biology of these cancers. In the present study we
have assessed the activity of NO synthase and its cellular
localisation in a series of human breast tumours.
Materials and metbods
Materials
All chemicals were from Sigma, Boehringer Mannheim or
BDH, unless otherwise indicated. L4U'4CJArgin ne was from
Amersham, UK.
Tissue collection
Tissue was collected from 34 breast tumours. Normal breast
tissue from six reduction mammoplasty specimens provided a
control group. Pieces of tissue (0.5-2.0 g) were divided into
two. One was placed immediately into medium (Dulbecco's
MEM, Gibco, Life Technologies, Paisley, UK) and prepared
for in vitro culture. The other was snap frozen and stored at
-70°C for subsequent assay for NO synthase and
immunohistochemistry studies.
Determination ofNO biosynthesis
Tissue was divided into 1 mm3 pieces, washed twice with
culture medium and placed into 96-well plates with 200 gll of
culture medium with or without NG-monomethyl-L-arginine
(L-NMMA). After 24 h culture at 3TC, in an atmosphere of
95% air/5% carbon dioxide concentration of nitrite + nitrate
in supernatants was analysed after reduction of nitrate using
cadmium (Thomsen et al., 1991). Nitrate was measured by
chemiluminescence (Palmer et al., 1987). NO biosynthesis
was determined by the difference in nitrite + nitrate concent-
rations in culture medium supernatants from wells containing
tissue biopsies relative to wells with culture medium alone.
Nitrite + nitrate concentration in culture medium alone
ranged from 0.5 to 1.0gM in all experiments. Total protein
content of tissue pieces was determined with bicinchoninic
acid reagent after solubilising the tissue with 1 M sodium
hydroxide. The limit of detection of nitrite by
chemiluminescence was 0.1 giM, equivalent to approximately
0.15 nmol mg-' protein. Results are expressed as mean
± standard error of the mean (s.e.m.), but data were com-
pared using the non-parametric Mann-Whitney rank test.
P<0.05 was considered statistically significant.
Assay ofNO synthase
Frozen tissue was extracted at 0-4°C by homogenisation
(with an Ystral homogeniser) in 2.5 volumes of a buffer
containing 320 mM sucrose, 20 mM Hepes, 1 mM EDTA,
1mM DL-dithiothreitol, 10ILgmlg ' leupeptin, lOLgmJm'
soybean trypsin inhibitor and 1 gLg ml-' pepstatin brought to
pH 7.2 at 20C with hydrochloric acid. The homogenates
were centrifuged at 10OOOg at 0-4°C for 30min. Super-
natants were passed through a 2ml column of cation-
exchange resin (AG 50W-X8, Bio-Rad) to remove
endogenous arginine and were stored on ice for up to 2 h
before use. Nitric oxide synthase in these supernatants
(cytosol plus microsomes) was measured by the conversion of
L-[U-'4Cargimne to [U-"C4citrulline at 37TC for 10min as
previously described (Salter et al., 1991). The activity of the
calcium-dependent enzyme was determined from the
difference between the [U-'4Cjcitrulhne generated from cont-
rol samples and samples containing 1 mM (ethylenebis(oxy-
ethylenenitrilo)Jtetracetic acid (EGTA); the activity of the
calcium-independent enzyme was determined from the
difference between samples containing 1 mM EGTA and
samples containing both 1 mM EGTA and 1 mM L-NMMA.
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Total protein content of tissue supernatants was determined
colorimetrically (Bio-Rad). The limit of detection in this
assay was 0.7 pmol min-' mg-' protein.
Histology and immunohistochemistry
Tumours were typed and ductal tumours were graded ac-
cording to Elston and Ellis (1991).
The immunohistochemical studies described below were
carried out on all the samples of breast cancer and normal
tissue included in this study. Sections (5jLM thick) were cut
from frozen tissue, air dried for 30 min then fixed in acetone
for 30 min. Two antibodies were used for NO synthase detec-
tion: (1) a monoclonal antibody to inducible NO synthase
from murine macrophages (ANTI-macNOS; Transduction
Laboratories, Lexington, KY, USA) which immunoreacts
with human inducible NO synthase (I Charles, unpublished
observation) and (2) polyclonal antiserum to NO synthase
raised in rabbits using purified rat brain NO synthase (Spnm-
gall et al., 1992). At the dilution used this antiserum has
proven reactivity with endothelial and neuronal constitutive
NO synthase isoenzymes across several species including
humans (Springall et al., 1992; Brave et al., 1993; Terenghi et
al., 1993). At a lower dilution (1:100) in Western blots this
antiserum also cross-reacts with inducible NO synthase
(Thomsen et al., 1994). Sections were incubated in 4% nor-
mal swine serum for 30 min before incubation with the
monoclonal antibody to inducible NO synthase (2.5 Lgm'l-)
or the polyclonal antiserum to NO synthase (diluted 1:1000)
for 16 h at 4°C. For macrophage detection, adjacent sections
were incubated for 30 min with antibodies raised in mouse
against the human monocyte/macrophage marker CD68
(3.4tg ml-') (EBM/1 1; Dako (UK)). Antibody labelling was
subsequently visualised using an avidin-biotin complex
method.
Results
Nitric oxide biosynthesis by cultured tissue
Nitrite + nitrate accumulated in culture medium during cul-
ture of tumour tissue pieces for 24 h (Table I). Nitrite + nit-
rate generation was significantly higher for the 14 invasive
tumours compared with normal controls (P<0.02). A case
of benign cystic change yielded concentrations higher than
normal controls but less than the mean value of invasive
tumours. Interestingly, in a case of in situ ductal carcinoma,
nitnrte + nitrate was higher than that observed in the normal/
benign cases, but again was lower than the mean for invasive
tumours. Within the group of ductal carcinomas, nitrite +
nitrate generation was greater in grade III than in grade H
tumours (P<0.03). Nitrite + nitrate was not detectable in
cultures of tissue from the grade I ductal carcinoma. An
invasive lobular carcinoma and a phyllodes tumour also
showed high concentrations of nitrite + nitrate in culture
medium after 24 h culture. Generation of nitrite + nitrate
was completely inhibited when tissue pieces were cultured in
the presence of 2 mM L-NMMA.
Nitric oxide synthase activity
Nitric oxide synthase activity was detected only in invasive
tumour tissue (Table II). For ductal carcinomas, activity was
detected in all grade III and in one of two grade II tumours.
Nitric oxide synthase was not detectable in tissue from the
grade I ductal carcinoma or benign tumours, or in normal
breast tissue. For all but two cases (one grade II and one
grade III ductal carcinoma) a proportion of the NO synthase
activity was found to be calcium independent.
Immunohistochemistry oftissue sections
We used a monoclonal antibody to inducible NO synthase to
identify and localise the inducible enzyme and a polyclonal
antiserum raised against purified rat brain NO synthase to
identify other NO synthase isoenzymes.
The monoclonal antibody to inducible NO synthase
labelled peritumoral spindle cells in the tumour stroma with
the morphology ofmacrophages (Figure la). These cells were
seen in stroma adjacent to invasive islands of tumour cells
and also in the stroma intimately associated with ducts
involved by in situ carcinoma. Occasional labelled cells were
also seen within solid tumour islands of grade HII invasive
ductal carcinomas and within ducts involved by in situ car-
cinoma. It was usually possible to recognise that these cells
had the morphology of macrophages, and in all cases serial
sections stained with the CD68 macrophage marker (EBM/
Table I Nitrite + nitrate biosynthesis by breast tissue cultured for 24h
Nitrite + nitrate
Tissue tipe No. ofcases (nmolmg-' protein; mean ± s.e.m.
Normal 4 0.0 _ 0.05
Benign cystic change 1 0.3
Ductal carcinoma in situ 1 1.5
Invasive tumours 14 1.9 ± 0.45a
Ductal grade I 1 0.0
Ductalgrade II 7 1.0 0.27b
Ductal grade III 4 3.8 ± 0.85c
Lobular carcinoma 1 3.3
Phyllodes tumour 1 1.8
'P<0.02 compared with normal tissue. bP<0.04 compared with normal tissue. cP<0.03
compared with grade II ductal carcinomas.
Table H NO synthase activity in breast tissue
NO synthase
No. (pmolmin-' mg-' protei; mean + s.e.m)
Tissue type ofcases Total Ca2+independet
Normal 3 <0.7 <0.7
Benign lesionsa 5 <0.7 <0.7
Invasive tumours 15 5.1 ± 1.4 2.3 ± 0.7
Ductal grade I 1 <0.7 <0.7
Ductal grade II 2 3.9 3.9 <0.7
Ductal grade III 7 8.5 2.2 3.7 1.1
Lobular carcinoma 4 3.3 1.8 2.0± 1.2
Poorly differentiated 1 4.9 0.9
'One benign cystic change, one stromal fibrosis and three fibroadenomas.11) confirmed their macrophage origin (Figure Ib). In sec-
tions from normal and benign breast tssue very occasonal
immunolabelling of stromal macrophages was seen. Few
endothelial or myoepithelial cells were also labelled with the
monoclonal antibody to inducible NO synthase.
The polyclonal antiserum to NO synthase also labelled
pentumoral spindle cells with the morphology of mac-
rophages. In addition, in both benign and malignant breast
tissue, immunolabelling of other cells incling vascular
endothelial (Figure Ic) and some myoepithelial cells (Figure
Id) was also observed. The labelling of these cells was much
more evident than that observed with the monoclonal
antibody to the inducible enzyme. Some immunopositive cells
remain unidentified at present.
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The present study shows that NO biosynthesis and NO
synthase activity are high for tumour tissue obtained from
primary human breast cancers compared with benign lesions
and normal breast tissue in which activity was low or not
detectable. Furthermore, NO biosynthesis was significantly
greater for tissue explants from grade HI compared with
grade II invasive ductal carcinomas. We have previously
reported that NO synthase is expressed in human
gynaecological tumours and, as with the present study, that
there is an assocation between NO synthase activity and
tumour grade (Thomsen et al., 1994).
T1he biochemical observations of calcium-independent
Fuge I Trssu from a grade III infiltrating ductal car m; showing (a)koxaition ofNO syntha in peritumoral spindle cells
with the monoconal antibody to inducible NO synthase (b) antigen loca1isation with the CD68 antibody, cirming that the
morphology and locaisation of those cel expressing NO synthae are the same as those exrssing the CD68 human monocyte/
macrophage antigen; and (c) laisation of NO synthase in endotheia cells within an infiltrating ductal carcioma, usng the
polyclonal antiserum to NO synthase. (d) Locahsation ofNO synthase in myoepitheialcells surrounding areas ofductal cinoma
in situ, using the polyclonal anisum to NO synthase. Bar = 50 nm.NO synth in hun brast cancer
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enzyme activity. and the generation of nitrite and nitrate
during culture of viable tumour tissue explants. suggest the
presence of inducible NO synthase (Knowles and Moncada.
1994). We have used a monoclonal antibody to inducible NO
synthase to determine the presence and localisation of this
isoenzvme. Consistent with the biochemiccal observations,
immunohistochemical studies revealed proteins immunoreac-
tive with this monoclonal antibody. This immunoreactivity
was localised predominantly within macrophages.
Calcium-dependent activity was also measurable. While
calcium-dependent NO synthase activity suggests the
presence of constitutive NO synthase isoforms. there are
examples in the literature for calcium-dependent inducible
NO synthase. and for induction of the neuronal and
endothelial NOS isoforms which were originally described as
constitutively expressed (reViewed in Knowles and Moncada.
1994). Further immunohistochemical studies using well-
characterised antibodies, as well as investigations using
molecular biology techniques, are required to determine the
specific NO synthase isoform(s) expressed in human breast
cancer tissue. However. consistent with the presence of cons-
titutive NO synthase was immunoreactive with the polyclonal
antiserum to NO synthase in these tumours. This antiserum,
which immunoreacts with endothelial and neuronal consti-
tutive NO synthases (Springall et al., 1992; Brave et al., 1993;
Terenghi et al., 1993). labelled vascular endothelial cells and
myoepithelial cells in addition to macrophages. In contrast to
gynaecological tumours in which immunolabelling with the
polyclonal antiserum to NO synthase was observed in
tumour cells (Thomsen et al.. 1994). breast tumour cells were
not immunolabelled with this antiserum or with the mono-
clonal antibody to inducible NO synthase.
The generation of NO by immune cells is an important
aspect of non-specific immunity in animals (Hibbs et al..
1990). Localisation of NO synthase within intratumoral mac-
rophages indicates that NO may also be involved in the
immune response in man. Previous investigations have shown
that macrophage infiltration is high in invasive ductal car-
cinomas of the breast regardless of tumour grade (Miles et
al., 1994). Interestingly. however, tumour necrosis factor. a
cytokine associated with cytotoxic macrophage functiops
(Sugarman et al.. 1985). is expressed predominantly within
tumour-associated macrophages of high-grade breast
tumours and expression is grade related (Miles et al., 1994).
This cytokine, which as a potent inducer of NO synthase
(Hibbs et al., 1990), may regulate the expression of NO
synthase in the tumour-infiltrating macrophage population.
While the generation of NO in breast tumours may cause
tumour cell cytostasis,cytotoxicity, it may also increase
tumour blood flow (Andrade et al., 1992; Wood et al., 1993)
and promote angiogenesis (Weidner et al.. 1992; Jenkins et
al., 1995). A balance in favour of the vascular effects may
explain the positive correlation between NO biosynthesis and
grade of malignancy.
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